Navigation Links
Golub Capital Provides Financing to Support The Recapitalization of Integrated DNA Technologies, Inc.
Date:4/23/2010

NEW YORK, April 23 /PRNewswire/ -- Golub Capital today announced that it has provided $12.0 million of senior subordinated debt to support the recapitalization and ongoing growth of Integrated DNA Technologies, Inc. ("IDT").  This transaction marks the first investment made by GC 2009 Mezzanine Partners, L.P., which is Golub Capital's sixth fund dedicated to middle market mezzanine debt financings.  The fund targets attractive net returns by investing primarily in mezzanine and second lien debt investments in U.S. middle market companies.

Headquartered in Coralville, Iowa, IDT is the leading supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides and genes. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT's manufacturing locations include facilities in Coralville, Iowa; San Diego, California; and Leuven, Belgium.

"We are excited to have the opportunity to partner with the IDT management team and to begin a lending relationship with the Company," commented Senior Managing Director Andrew Steuerman. "IDT has built its market leading position over the last 25 years by delivering exceptional product quality and building longstanding customer relationships."

"This is our first time working with Golub Capital," noted Dr. Joseph Walder, IDT's founder and CEO.  "The financing provided by Golub Capital will help ensure that IDT maintains a strong balance sheet and has the flexibility necessary to pursue our ambitious plans for the future."

About Golub Capital

With $4 billion in capital, Golub Capital is a leading provider of financing solutions for the middle market, including one-loan financings (through the firm's proprietary GOLD facility), senior, second lien and subordinated debt, preferred stock and co-investment equity. The firm also underwrites and syndicates senior credit facilities up to $200 million. Golub Capital's hold sizes range from $10 million to $75 million per transaction.  Golub Capital was ranked by Thomson Reuters Loan Pricing Corporation as the #1 Traditional Middle Market Bookrunner for 2009.  For two years in a row, Golub Capital was named "Middle Market Lender of the Year" by Buyouts Magazine for achievements in 2009 and 2008.  Other honors awarded to Golub Capital include being named "2009 Mezzanine Financing Agent of the Year" and "2008 Financing Firm of the Year" by M&A Advisor and "2008 M&A Lender of the Year" by ACG's Mergers & Acquisitions. Golub Capital is a national firm with offices in Chicago, New York and Atlanta. For more information, please visit the firm's website at www.golubcapital.com.

Golub Capital Incorporated (and its various affiliates) creates and manages multiple private funds.  One of its affiliates, GC Advisors LLC is an investment advisor registered with the United States Securities and Exchange Commission. 


'/>"/>
SOURCE Golub Capital
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Golub Capital Provides Debt Financing to Support the Acquisition of DNA Diagnostics Center, Inc. by MTS Health Investors, LLC
2. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
3. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
4. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
5. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
6. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
7. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
8. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
9. Luminex Corporation to Present at Americas Growth Capital Emerging Growth Conference
10. Altheus Therapeutics Secures $3.6 Million in Venture Capital
11. XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
Breaking Biology Technology:
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
Breaking Biology News(10 mins):